Seaport Therapeutics SPTX Cash Flow Statement (2024-2026)

NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Seaport Therapeutics Quarterly Cash Flow Statement

Periods 8 quarters
Latest Sep 2026

Seaport Therapeutics reported cash from operations of -$22.68M and free cash flow of -$22.68M for the quarter ended Sep 2026, down 43.9% year over year. This cash flow statement covers 8 quarters of results from Dec 2024 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income -13.13M-15.08M-22.54M-24.14M-25.41M-62.60M-26.39M
Depreciation and DepletionDep. & Depletion 0.04M0.04M0.05M0.04M0.03M0.03M0.03M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges -0.84M-1.18M-0.94M-0.22M-0.36M-0.55M
Depreciation & Amortization (CF)Dep. & Amort. 0.04M0.04M0.05M0.04M0.03M0.03M0.03M
Share-based CompensationStock Comp. 1.62M1.76M1.79M1.72M2.57M36.86M2.45M
Other non-cash itemsOther Non-Cash 0.28M0.31M0.32M0.32M0.33M0.33M0.33M
Change in Working Capital
Change in Account PayablesChange Payables -2.00M-0.60M2.40M-2.52M2.78M0.91M0.11M
Change in Accrued ExpensesChange Accrued Exp. -1.87M2.58M2.47M0.77M-1.50M1.04M1.42M
Change in Other Operating AssetsOther Assets Change 3.85M2.84M-1.01M-11.89M-1.57M2.00M-0.25M
Change in Other Operating LiabilitiesOther Liabilities Change -0.23M-0.54M-0.31M0.04M-0.32M-0.34M-0.33M
Other Working Capital ChangesOther WC Changes -4.08M-3.38M0.70M11.93M1.25M-2.34M-0.08M
Cash from OperationsCash from Ops. -20.21M-15.33M-15.77M-26.65M-20.17M-26.14M-22.68M
Investing Activities
Capital ExpendituresCapex 0.05M0.27M0.01M-0.69M
Change in Property, Plant and EquipmentChange in PP&E -0.05M-0.27M-0.01M0.69M
Purchase of InvestmentsInvestments Purchased 225.50M78.67M49.90M-750.46M47.15M253.50M24.89M
Sale and Maturity of InvestmentsInvestments Sold 77.50M65.00M70.00M75.00M50.00M45.00M
Cash from Investing ActivitiesCash from Investing -225.55M-1.44M15.09M27.66M27.85M-203.50M20.11M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued 0.00M
Net Shares Issued and RepurchasedNet Shares Issued 0.00M
Net Equity Issued and RepurchasedNet Equity Issued 0.00M
Other financing activities (as filed) -0.78M
Cash from Financing ActivitiesCash from Financing 0.00M-0.87M-0.78M240.93M-0.10M
Additional items
Exchange Rate EffectFX Effect 0.03M-0.03M-0.03M0.03M-0.01M
Change in Cash -245.76M-16.77M-0.64M0.11M6.87M11.31M-2.67M
Ending Cash Balance 309.55M63.80M47.03M46.39M46.50M53.36M64.68M62.01M
Free Cash FlowFCF -20.26M-15.59M-15.77M-25.96M-20.17M-26.14M-22.68M
Net Cash FlowNCF -245.76M-16.77M-0.67M0.14M6.90M11.29M-2.67M

Seaport Therapeutics Cash Flow Statement API

Pull Seaport Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SPTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY